Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluating Nivolumab for patients with surgically resectable Stage IIB-IIC melanoma has completed.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma [NA]
Clinical trial update on a study examining alterations in tumor metabolism associated with immunotherapy resistance in melanoma; currently r…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study [NA]
This clinical trial update describes a microdosing PET imaging study using a 124I-labeled cRGDY silica nanomolecular particle tracer in pati…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Contrast-enhanced Ultrasound for Sentinel Node Detection [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial sponsored by The Netherlands Cancer Institute is evaluating contrast-enhanced ultrasound for sentinel lymph…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Comparison of Two Strategies for Counseling Skin Examination and Sun Protection in First-degree Relatives of Patients With Melanoma [NA]
A completed clinical trial comparing two strategies for counseling skin examination and sun protection in first-degree relatives of patients…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
A clinical trial update describing validation of molecular diagnostic assays that detect cancer biomarkers in blood and primary tumors. The …
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma [Phase 1]
A Phase I study of a personalized neoantigen cancer vaccine in melanoma has completed with results posted.
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
A clinical trial evaluating anti-PD-1 therapy by monitoring T cell responses in melanoma, lung cancer, and other cancers; currently recruiti…
-
CLINICAL_TRIALS withdrawal · 2025-12-24Clinical Trial Update: STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma [Phase 1]
A Phase 1 study of STIL101 for injection across pancreatic ductal adenocarcinoma, colorectal cancer, renal cell carcinoma, cervical cancer, …
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021
A single-center retrospective study from University Hospital Strasbourg (2013–2021) examines factors that predict complete response to immun…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS) [NA]
This clinical trial update describes a telemedicine and mobile health symptom management intervention for advanced cancer patients (FOCUS), …
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors [Phase 1]
A Phase 1 study evaluating KIN-2787 in participants with BRAF and/or NRAS mutation-positive solid tumors. The study includes patients with n…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab [Phase 1]
Phase 1 update of SX-682 in metastatic melanoma patients treated with pembrolizumab (stages III/IV); the trial is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: A Study of GC101 TIL in Advanced Melanoma (BZ) [Phase 1, Phase 2]
Phase 1/2 study of GC101 TIL in advanced melanoma has completed, evaluating tumor-infiltrating lymphocyte therapy.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating infliximab or vedolizumab to treat immune checkpoint inhibitor-related colitis in patients with genito…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: A Study of GC101 TIL in Advanced Melanoma [Phase 2]
A Phase 2 clinical trial evaluating GC101 TIL in advanced melanoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI... [Phase 2]
Phase 2 randomized trial evaluating adoptive cell therapy with tumor-infiltrating lymphocytes plus interleukin-2 in metastatic melanoma, wit…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study) [Phase 2]
An update on a Phase 2 study evaluating SCIB1 and iSCIB1+ in melanoma patients treated with checkpoint inhibitors (nivolumab+ipilimumab or p…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Investigation of the ROle of faT and inflAmmaTory Cells in mElanoma
This entry describes a clinical trial investigating the role of fat and inflammatory cells in melanoma; recruitment has not yet begun.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: An Expanded Access Program for VO (RP1) in Combination With Nivolumab in Patients With Advanced Melanoma
This update notes that the Expanded Access Program for VO (RP1) in combination with nivolumab for advanced melanoma is no longer available.
-
CLINICAL_TRIALS withdrawal · 2025-12-18Clinical Trial Update: Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma
The compassionate use program for trametinib and dabrafenib in BRAF-mutant metastatic melanoma has ended and is no longer available.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of INBRX-106 in combination with pembrolizumab for locally advanced or metastatic sol…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma [Phase 1, Phase 2]
A Phase 1/2 study evaluating the combination of duvelisib with nivolumab in patients with advanced unresectable melanoma has been terminated…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV Melanoma [Phase 2]
A Phase 2 clinical trial update evaluating two combination regimens for BRAFV600-mutant metastatic or unresectable melanoma: nivolumab with …
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
A clinical trial update announcing a liquid biomarker study in melanoma and non-melanoma skin cancers that is currently recruiting.